News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Magnus Nilsson discusses when and why we should operate in esophageal cancer
Photo of Magnus Nilsson at esmo.org
Jun 29, 2024, 10:24

Magnus Nilsson discusses when and why we should operate in esophageal cancer

Lizzy Smyth, Consultant Medical Oncologist in upper GI oncology at Oxford University, shared on X:

“ESMOGI24 loves surgeons! Magnus Nilsson discusses when and why we should operate in esophageal cancer. Multidisciplinary research is critical to improve outcomes.”

Magnus Nilsson

Source: Lizzy Smyth/X

cancer ESMOGI24 esophageal cancer Lizzy Smyth Magnus Nilsson OncoDaily Oncology Oxford University
Insight
Aug 18, 2024, 16:02
Isaac Kohane: AI can be the Great Leveller for cancer care
Insight
Aug 18, 2024, 15:58
SIOP Programs Update - July 2024
Insight
Aug 18, 2024, 15:54
Andrea Maliachi: The p value, its limitations and misleading use in medical research
Insight
Aug 18, 2024, 15:44
Amanda Nickles Fader: It’s a great time to become a FWC scholar
Blog
Aug 18, 2024, 15:27
Cheng Ean Chee: Privileged to co-chair the HCC session at the Singapore Hepatology Conference
Blog
Aug 18, 2024, 15:24
Aruni Ghose: The Best Team that I’ve worked with when it comes to Cancer Reach and Coverage
Blog
Aug 18, 2024, 15:17
EM Oncology team participating in ESMO 24 - Dr. Reddy's Laboratories
Blog
Aug 18, 2024, 15:16
CCR researchers have created a massive data resource for treating lung cancer - NCI Center for Cancer Research
Blog
Aug 18, 2024, 15:13
Modupe Elebute-Odunsi: Community Engagement to Increase Cancer Prevention Awareness
Blog
Aug 18, 2024, 15:10
Sami Mansfield: An excellent read from our UK colleagues about cancer risks and prevention
Blog
Aug 18, 2024, 15:09
Hil Moss: Cancer risk in Gen X/Millennials is both harrowing and a critical read
Blog
Aug 18, 2024, 15:03
Jorge Cortes: Olutasidenib among patients with R/R AML mIDH1 previously treated with venetoclax